CVS Shares Jump After Broad Q1 Beat and Higher 2026 Guidance
CVS Health surged in morning trading after reporting a substantial first-quarter 2026 earnings beat and lifting its full-year guidance. Adjusted EPS came in at $2.57 versus roughly $2.21 expected, while revenue reached $100.4 billion compared with about $95 billion consensus. Management cited improvement at the Health Care Benefits segment and stro…